Skip to main content
. 2021 Mar 22;13(6):1443. doi: 10.3390/cancers13061443

Figure 2.

Figure 2

ERBB2 expression on alveolar rhabdomyosarcoma (aRMS) cells. RH30, RH41, and (A) primary tumor cell suspensions showed different variability in size (forward (FSC) vs. side scatter (SSC)) and displayed low but homogenous ERBB2 expression compared to isotype controls. The MDA-MB-453 and MDA-MB-468 breast cancer cell lines served as positive and negative controls, respectively (B,D). Compared to tumor cell suspensions stable ERBB2 expression was detectable on tumor spheroids during tumor growth (C,E).